Whether you are healthy or have a medical condition, there are opportunities to participate in a research study. Health research ranges from simple questionnaires or screening tests, to clinical trials of a new drug or device.
The purpose of this study is to understand the short- and long-term impacts of COVID-19 on social, psychological and behavioural aspects of sexual health.
The purpose of this study is to explore brain energetics using Bold fMRI and FDG PET scanning in healthy controls. We will complete fMRI and FDG PET scanss on 30 healthy volunteers, obtaining a set of healthy control data using the recently acquired Signa Hybrid Positron Emission Tomography/3T M
The purpose of this study is to develop a monitoring tool that can measure body movement, mood, and disease symptoms from video recordings in the home setting.
The purpose of this study is to explore sequences for functional magnetic resonance imaging (MRI) under a variety of conditions, using various stimuli to obtain healthy control data for comparison with other patient populations with brain diseases such as Alzheimer's and Parkinson's.
The purpose of this study is to validate the English version of a new cognitive screening tool, the "Dépistage Cognitif de Québec" (DCQ). The DCQ is a valid instrument that can be administered in less than 45 minutes and unlike other screening tools for dementia, it can provide more detailed inf
Research has shown that Alzheimer’s disease can cause changes in a person’s speech and eye-movements. As neurodegeneration progresses, gaze and language pathways are disrupted.
This is an observational study designed to better understand the factors that contribute to MS disease progression using tools from different fields such as epidemiology (i.e.
While conventional MRI techniques take a qualitative image, our advanced MRI technique programs the scanner to function more like a quantitative measuring instrument to measure myelin - the insulating layer around the “wires” in the brain.
The purpose of this study is to determine the relationships among the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's disease (AD), as the pathology evolves from normal aging through very mild symptoms, to mild cognitive impair
Participants will complete a series of computerized cognitive tests and two health questionnaires. The performance of young stroke patients will be compared to healthy controls for each computerized cognitive test.